USPTO serial 98015779
Serial No. 98015779
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- NEW APPLICATION PROCESSING
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 98015779?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Nashville, TN
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Edward D Lanquist, Jr.
EDWARD D LANQUIST, JR. BAKER DONELSON1600 WEST END AVENUE, SUITE 2000NASHVILLE, TN 37203Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 044 | Consultation services in the fields of health care, medical, pharmaceutical and population health data, namely, data analytics, namely, data and medical analysis for the treatment of persons at end-of-life, readmission risk analysis, namely, data and medical analysis for the treatment of persons at end-of-life, hospitalization risk analysis, namely, data and medical analysis for the treatment of persons at end-of-life, predictive modeling, namely, data and medical analysis for the treatment of persons at end-of-life and predictive reporting, namely, data and medical analysis for the treatment of persons at end-of-life; providing health care information; providing health related analytics, namely, readmission risk analysis, namely, data and medical analysis for the treatment of persons at end-of-life, hospitalization risk analysis, namely, data and medical analysis for the treatment of persons at end-of-life, predictive modeling, namely, data and medical analysis for the treatment of persons at end-of-life and predictive reporting, namely, data and medical analysis for the treatment of persons at end-of-life; providing web-based access to health related analytics, namely, readmission risk analysis, namely, data and medical analysis for the treatment of persons at end-of-life, hospitalization risk analysis, namely, data and medical analysis for the treatment of persons at end-of-life, predictive modeling, namely, data and medical analysis for the treatment of persons at end-of-life and predictive reporting, namely, data and medical analysis for the treatment of persons at end-of-life | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 15, 2023 | MAB1 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | — |
| Aug 15, 2023 | MAB1 | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | — |
| Aug 15, 2023 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Aug 14, 2023 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Jun 29, 2023 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jun 28, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 30, 2023 | NWAP | NEW APPLICATION ENTERED | — |